Merck to Hold Fourth-Quarter 2010 Sales and Earnings Conference Call on Feb. 3
January 4, 2011 7:11 pm ET
Management to present at Goldman Sachs conference on Jan. 6
WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK) will hold its fourth-quarter 2010 sales and earnings conference call with institutional investors and analysts beginning at 8 a.m. EST on Thursday, Feb. 3. During the call, Kenneth C. Frazier, chief executive officer, Peter N. Kellogg, executive vice president and chief financial officer, and Adam H. Schechter, president, Global Human Health, will provide an overview of Merck’s financial performance for the quarter.
Journalists are invited to listen-only by calling (706) 758-9928 or (800) 399-7917. At the conclusion of the call, journalists who wish to ask questions are invited to call Media Relations. A replay of the call will be available starting at 11 a.m. EST on Feb. 3 through 11:59 p.m. EST on Feb. 11. To listen to the replay, dial (706) 645-9291 or (800) 642-1687 and enter ID No. 30176534.
Investors, journalists and the general public may access a live audio webcast of the call on Merck’s Web site at http://www.merck.com/investors/events-and-presentations/home.html. Software needed to listen to the webcast is available on the corporate Web site and should be downloaded prior to the beginning of the webcast. A replay of the webcast will be available at approximately 11 a.m. EST on Feb. 3 and will remain on the website for 12 months. The fourth-quarter sales and earnings news release and supplemental financial disclosures also will be available in the Newsroom.
Separately, the company also announced that Richard T. Clark, chairman, and Mr. Frazier will be presenting at the Goldman Sachs CEO Unplugged conference at 11 a.m. EST on Thursday, Jan. 6. Merck will provide a live audio webcast of their remarks on the company’s web site at http://www.merck.com/investors/events-and-presentations/home.html.
About Merck
Today’s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com.
Merck
Media:
Steven Campanini, 908-423-4291
or
Investor:
Joe Romanelli, 908-423-5088
